Doliver Advisors’s Clorox CLX Stock Holding History

Doliver Advisors’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,433	Closed	-$258K	–	174
2021 Q2	$258K	Sell	1,433 -100	-7%	-$18.3K	0.09%	126
2021 Q1	$296K	Buy	+1,533	New	+$295K	0.11%	105

Other funds holding CLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

CRC

Cedar Rock Capital London, United Kingdom $4.05B AUM 21.89% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Doliver Advisors's CLX Position: Q3 2021 in Review

Doliver Advisors sold out of Clorox (CLX) in Q3 2021, closing a stake of 1,433 shares — an estimated $258K sold.

Doliver Advisors first reported a position in CLX in Q1 2021 and held it in 2 quarters. The position peaked at $296K in Q1 2021. 1,134 funds tracked by Wall St. Rank hold CLX as of Q3 2021.

Doliver Advisors reported no remaining Clorox position as of Q3 2021 after selling out during the quarter.
Doliver Advisors sold 1,433 Clorox shares in Q3 2021, an estimated $258K.
Doliver Advisors first reported a position in Clorox in Q1 2021 and held it in 2 quarters.
Doliver Advisors's Clorox position peaked at $296K in Q1 2021.
1,134 funds tracked by Wall St. Rank held Clorox as of Q3 2021.

Based on Doliver Advisors's 13F filing for Q3 2021, filed 3 Nov 2021.